Key Highlights

  • Michael Reger, founder of Northern Oil and Gas, was named president of new Subsidiary Callan Power, formed to pursue domestic transformer and power-grid equipment manufacturing.
  • Callan Power signed a definitive agreement to acquire Williston Basin oil and gas assets, with the company projecting cumulative net Operating Cash Flow of $252 million over the wells' operating lives.
  • The company also announced a $60 million advanced electrical Manufacturing venture with Bia Power Systems and Alabama State University in Brewton, Alabama.
  • Callan JMB regained compliance with Nasdaq's minimum bid price requirement on August 17, 2026.

Callan JMB Inc. (NASDAQ:CJMB), a small-cap thermal-logistics company, is rapidly diversifying into energy and advanced manufacturing through a series of new ventures announced this summer.

The most recent and highest-profile development is the appointment of Michael Reger, founder of Northern Oil and Gas, as president of Callan Power, a subsidiary the company formed to pursue domestic manufacturing of transformers and other critical power-grid equipment.

Callan Power has also signed a definitive agreement to acquire Williston Basin oil and gas Assets from an entity called Reger Oil, extending the company's Diversification into conventional energy production.

The Callan Power Subsidiary

Callan Power LLC was formed on August 6 to pursue transformer and electrical-equipment manufacturing, with Michael Reger's appointment as president bringing experienced oil-and-gas Leadership to the new venture. The subsidiary represents a significant expansion beyond the company's original cold-chain logistics footprint.

The Williston Basin Acquisition agreement, signed under Callan Power, projects cumulative net operating cash flow of $252 million over the wells' operating lives, according to the company's disclosures.

Manufacturing and Infrastructure Ventures

Callan JMB has generated an unusually high cadence of press releases in July and August 2026. It announced a strategic Partnership with Alabama State University tied to a planned Atlas Complex pharmaceutical manufacturing campus in Marion, Alabama, and held a groundbreaking ceremony for that project on July 29.

Weeks later, the company announced a $60 million advanced electrical manufacturing venture with Bia Power Systems and Alabama State University in Brewton, Alabama, further building out its manufacturing ambitions.

Nasdaq Compliance

On August 17, Callan JMB announced it had regained compliance with Nasdaq's minimum bid price requirement, an important step in maintaining its exchange listing as the company pursues its diversification strategy.

Maintaining that compliance will likely remain relevant as the company continues to expand into capital-intensive new Business lines.

Financial Position

Callan JMB remains a small company by conventional metrics. Trailing twelve-month Revenue is approximately $5.1 million, down from full-year 2025 revenue of about $5.72 million, itself a roughly 13% decline from the prior year. The company reported a net loss of roughly $9.8 million on a trailing basis.

The company's legacy business, cold-chain shipping through its Coldchain Technology Services subsidiary, continues to operate alongside the newly announced ventures, which will require significant Capital to develop.

What Comes Next

Investors should monitor whether the Williston Basin acquisition by Callan Power closes on the terms described and whether the projected $252 million in cumulative cash flow begins to show up in financial disclosures. The progress of the $60 million Alabama electrical manufacturing venture with Bia Power Systems, including any construction milestones or financing details, will be an important signal of execution.

The company's next quarterly filing should clarify how these new ventures are being capitalized and whether legacy cold-chain revenue has stabilized alongside the new business lines.

A Rapid Diversification Into Energy and Manufacturing

Callan JMB is executing an ambitious diversification strategy, moving from its legacy cold-chain logistics business into pharmaceutical infrastructure, electrical manufacturing, and now conventional energy assets under experienced leadership.

The company's underlying financials remain modest, and the rapid expansion into capital-intensive new businesses will require successful execution and financing to translate into meaningful revenue and cash flow.